Ruiang Gene (688217)
SSE · 688217
Market Cap$1.3B
Revenue$162.8M
Employees336
Listed OnSSE
Ticker688217
CEO / ExecMr. Shangxian Gao
HeadquartersShanghai
MarketMainland China
Websitewww.rightongene.com
Overview
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China. The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.